Molnupiravir is easier to administer in an outpatient environment, necessitates only temporary oral administration, and so has greater compliance. The benefit of a medicine including molnupiravir is always that, in contrast to other EUA authorized treatment options for COVID-19, made on a better scale, it does not desire cold storage https://darbufelone24566.post-blogs.com/49490432/article-under-review